Preparation and first evaluation of [18F]FE@SUPPY: a new PET tracer for the adenosine A3 receptor

Nuclear Medicine and Biology

Volumn 35, Issue 1, 2008, Pages 61-66

  Wadsak, Wolfgang ^a,b   Mien, Leonhard Key ^a,b   Shanab, Karem ^b   Ettlinger, Dagmar E ^a   Haeusler, Daniela ^a,b   Sindelar, Karoline ^a   Lanzenberger, Rupert R ^a   Spreitzer, Helmut ^b   Viernstein, Helmut ^b   Keppler, Bernhard K ^b   Dudczak, Robert ^a   Kletter, Kurt ^a   Mitterhauser, Markus ^a,b,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adenosine; Fluorine 18; PET; Radioligand; Receptor

Indexed keywords

5 (2 FLUOROETHYL) 2,4 DIETHYL 3 (ETHYLSULFANYLCARBONYL) 6 PHENYLPYRIDINE 5 CARBOXYLATE F 18; ADENOSINE A3 RECEPTOR; FLUORINE 18; UNCLASSIFIED DRUG;

ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG STRUCTURE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT;

ANIMALS; AUTORADIOGRAPHY; FLUORINE RADIOISOTOPES; MALE; NICOTINIC ACIDS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTOR, ADENOSINE A3; TISSUE DISTRIBUTION;

EID: 37349054485     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.09.004     Document Type: Article

References (20)

1. Baraldi P.G., Cacciari B., Romagnoli R., Merighi S., Varani K., Borea P.A., et al. A3 adenosine receptor ligands: history and perspectives. Med Res Rev 20 (2000) 103-128
2. Merighi S., Varani K., Gessi S., Cattabriga E., Iannotta V., Ulouglu C., et al. Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375. Br J Pharmacol 134 (2001) 1215-1226
3. Suh B.C., Kim T.D., Lee J.U., Seong J.K., and Kim K.T. Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells. Br J Pharmacol 134 (2001) 132-142
4. Gessi S., Varani K., Merighi S., Cattabriga E., Iannotta V., Leung E., et al. A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study. Mol Pharmacol 61 (2002) 415-424
5. Fishman P., Bar-Yehuda S., Madi L., and Cohn I. A3 adenosine receptor as a target for cancer therapy. Anticancer Drugs 13 (2002) 1-8
6. Fishman P., Bar-Yehuda S., Ardon E., Rath-Wolfson L., Barrer F., Ochaion A., et al. Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist. Anticancer Res 23 (2003) 2077-2083
7. Madi L., Ochaion A., Rath-Wolfson L., Erlanger A., Ohana G., Harish A., et al. The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition. Clin Cancer Res 10 (2004) 4472-4479
8. Liang B.T., and Jacobson K.A. A physiological role of the adenosine A3 receptor: sustained cardioprotection. Proc Natl Acad Sci U S A 95 (1998) 6995-6999
9. von Lubitz D.K., Ye W., McClellan J., and Lin R.C.S. Stimulation of adenosine A3 receptors in cerebral ischemia. Neuronal death, recovery, or both?. Ann N Y Acad Sci 890 (1999) 93-106
10. Avila M.Y., Stone R.A., and Civan M.M. Knockout of A3 adenosine receptors reduces mouse intraocular pressure. Invest Ophthalmol Vis Sci 43 (2002) 3021-3026
11. von Lubitz D.K., Simpson K.L., and Lin R.C. Right thing at a wrong time? Adenosine A3 receptors and cerebroprotection in stroke. Ann N Y Acad Sci 939 (2001) 85-96
12. Laudadio M.A., and Psarrapoulou C. The A3 receptor agonist 2-Cl-IB-MECA facilitates epileptiform discharges in the CA3 area of immature rat hippocampal slices. Epilepsy Res 59 (2004) 83-94
13. Li A.H., Moro S., Forsyth N., Melman N., Ji X.D., and Jacobson K.A. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J Med Chem 42 (1999) 706-721
14. Lopes L.V., Rebola N., Pinheiro P.C., Richardson P.J., Oliveira C.R., and Cunha R.A. Adenosine A3 receptors are located in neurons of the rat hippocampus. NeuroReport 26 (2003) 1645-1648
15. Okada M., Kawata Y., Kiryu K., Mizuno K., Wada K., Tasaki H., et al. Effects of adenosine receptor subtypes on hippocampal extracellular serotonin level and serotonin reuptake activity. J Neurochem 69 (1997) 2581-2588
16. Zhu C.B., Hewlett W.A., Feoktistov I., Biaggioni I., and Blakely R.D. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Mol Pharmacol 65 (2004) 1462-1474
17. Fredholm B.B., Arslan G., Halldner L., Kull B., Schulte G., and Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn-Schmiedeberg's Arch Pharmacol 362 (2000) 364-374
18. Jenner T.L., Mellick A.S., Harrison G.J., Griffiths L.R., and Rose'Meyer R.B. Age-related changes in cardiac adenosine receptor expression. Mech Ageing Dev 125 (2004) 211-217
19. 18F]FETO. Eur J Nucl Med Mol Imaging 33 (2006) 928-931
20. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th ed. (1998), Academic Press, San Diego